June JAAD: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Hidradenitis Suppurativa Foundations
Release Date:
Suiting Ao, MD and Wang Fang, MD interviewed by Steven Chen, MD, FAAD
June JAAD: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Hidradenitis Suppurativa Foundations